Philip Morris
Q&A with FDA
Fields
- Author
- Blackard, C.Z.
- Type
- PUBL, PUBLICATION, OTHER
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Attachment
- 2048261193/2048261210
- Site
- N403
- Request
- Stmn/R1-098
- Stmn/R1-099
- Named Person
- Kessler, D.
- Ohara, J.
- Zeller, M.
- Ohara, J.
- Document File
- 2048260734/2048261431/Product Integrity - FDA@ 2048261164/2048261430/FDA - Tobacco Regulation
- Named Organization
- Congress
- FDA, Food and Drug Administration
- Hhs, Dept of Health and Human Services
- FDA, Food and Drug Administration
- Author (Organization)
- Tobacco Reporter
- Litigation
- Stmn/Produced
- Master ID
- 2048261193/1210
Related Documents: - Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- ghq92e00
Document Images
tobacco
R-.= EF . P~' 0`` R:. T' E R
PASSPORT TO
da4A
W l~-I
~A
T ~
By Colleen Zimmerman Blackard
T he swarm brought a little smile
to my face. Here, at the
Department of Health and
Human Services building, home
to the Food & Drug Administration in
Rockville, Maryland, outside the front
entrance's plate glass doors, were ash-
trays. And huddled around, lighting
up, inhaling and exhaling, and stub-
bing out, were 12 smokers.
Some might have been visitors,
surely others were employees.
Although running against the clock, I
was compelled to stand with them for
a moment, light up, and commune
with a nod and a smile and an occa-
sional roll of the eyes.
Then I went inside.
Like many government buildings,
FDA is situated in a maze of blank off-
white corridors and shiny tiled floors.
A sterile environment for the national
government's hive of health policy.
FDA Commissioner David Kessler
was unavailable to mct~: .,ith TR. So
Jim O'Hara, FDA associate commis-
sioner for public affairs, and Mitch
Zeller, special assistant for policy,
answered questions instead.
Here, a summary of what's on the
FDA's mind.
TR: Why didn't Commissioner
Kessler pursue his tobacco agenda
during the Bush Administration,
when he was appointed?
O'Hara: The genesis of the agency's
thinking dates back to the Bush
Administration. Shortly after he was
named to his post, he considered a
petition from COSH (the Coalition on
Smoking OR Health)....We began seri-
ously looking at the issue in 1991.
TR: How many people-what per-
centage of employees-are devoted
to tobacco-related issues at FDA?
O'Hara: We use people as needed to
address specific questions. For the nico-
tine addiction question, a number of
people participated at one time or
another. It's almost impossible to
count.
Zeller: But if you take all of these
people and put them on a full-time
employee equivalent basis, fewer than
two dozen have been devoted to tobac-
co issues. And that's out of 10,000
employees.
O'Hara: But if vou counted all of
the names, it would be a few dozen.
Some worked on it for a day, some a
week.
TR: Is the agency neglecting its
mission by pursuing tobacco regula-
tory authority? One congressman
has said that expanding FDA author-
ity is not the answer, particularly
when approving life-saving drugs
can take years.
O'Hara: The fact is, this agency is
reviewing and approving drugs, in
record time. Historically, during the
1980s, review and approval took 26 to
27 months. In 1994. the median time
was 19.1 months. We have significant-
ly decreased the agency's historical
average. And for important therapeutic
drugs under the user fee program, the
review/approval process is 10.4
months. We're reviewing and approv-
ing drugs faster than ever before. [In
future] we will be reviewing all drugs in
12 months, and for important thera-
pies, six months.
To say that the FDA is not pursuing
its core mission is wrong.
TR FDA wants to regulate tobac-
co: under what authority?
Zeller: Under a combination drug
and device authority. Nicotine is the
drug, and cigarettes and smokeless
tobacco are the nicotine delivery devices.
2Q48i61194

O'Hara: The law provides us to
choose our approach. We have a lot
of flexibility on how we approach
sales, use and distribution of the
product.
TR: How can tobacco be declared
legal by FDA if it can't declare it
"safe" and "effective" as it is
required to?
O'Hara: As I said, under the restric-
tive device provisions under the
statute.
TR: Doesn't the Federal Trade
Commission have jurisdiction over
tobacco advertising?
Zeller: FTC's jurisdiction is not
exclusive. What we want to do is
reduce access and reduce appeal. We
have the legal authority to do that.
Adult smoking rates are going
down; kids' smoking is increasing. This
is a kids' issue. It's not about adults; it's
about preventing children from smok-
ing, preventing the next generation
from being hooked.
We have 40 million tobacco users
who are addicted. Studies show that
nicotine is more addictive than heroin
and cocaine. We have a public health
issue to grapple with, but the commis-
sioner has said under oath-many
times-that he's not out to ban ciga-
rettes.
TR: Why not?
O'Hara: A ban wouldn't work. The
agency's strategy is to keep kids from
getting hooked in the first place.
Zeller: We can't do it by ourselves.
We have to change the environment in
which tobacco is sold. This isn't a Big
Brother issue. We're providing the tools
to help keep kids from using tobacco.
And with those tools, anyone who
cares can use them. It's up to the rest of
us to use those tools.
O'Hara: The industry has said
repeatedly that we are going to do
things we haven't said and haven't
done.
TR: Why not have the FTC, or
another agency that already regu-
lates the tobacco industry, expand its
jurisdiction? Was there any investi-
gation by your agency, or another
government agency, to expand juris-
diction already in force?
O'Hara: The investigation we
undertook was within our jurisdiction.
But no, I'm not aware of any other
investigation [to expand jurisdiction]
by any govemment agency.
TR: In Dr. Kessler's letter to Scott
Ballin, chairman of the Coalition on
Smoking OR Health, he says a strict
application of agency provisions
could mean, ultimately, removal
from the market of tobacco products
containing nicotine at levels that
cause or satisfy
addiction.
O'Hara: But
in the follow-
ing paragraph
he says he
would not
pursue a
ban.
[Editor's
Note: What
Dr. Kessler
actually says
in the follow-
ing paragraph(s),
in his letter to Ballin
of Feb. 25, 1994, is:
"Given the wide-
spread use of ciga-
rettes and the preva-
AuNo2try.
lence of nicotine addiction, such a
regulatory action could have dramat-
ic effects on our society. One must
consider the possible effects of the
loss of this source of nicotine on the
health of some people who are
addicted to nicotine and the possible
need for a weaning period. It is also
important to consider the potential
for a black market in nicotine-con-
taining cigarettes.
"We recognize that the regulation of
cigarettes raises societal issues of great
complexity and magnitude. It is vital
in this context that Congress provide
clear direction to the agency. We
intend therefore to work with Congress
to resolve, once and for all, the regula-
tory status of cigarettes under the Food,
Drug and Cosmetic .'u.t."]
TR: How does the FDA define
addiction?
O'Hara: An advisory committee has
looked at this. Every major medical
group has looked at this question, and
each has said cigarettes are addictive.
Is there a level below which nicotine in
cigarettes is not addictive? We don't
have a clue what that level is. There are
researchers looking at it, though, inde-
pendently.
TR: When the FDA asserted it had
jurisdiction over tobacco, it surely
expected a lawsuit, which of course
delays action. Isn't it in youths' best
interest to allow Congress to legis-
late or work for a voluntary agree-
ment with the tobacco industry,
which could take effect quickly,
rather than assert jurisdiction and
tie up your proposal in court for per-
haps years?
O'Hara: It's the industry that's
going to tie this up in court. If the
industry is serious about wanting to
keep kids off cigarettes, it's time the
industry's actions matched its words.
The industry can try to improve the
proposal.
TR: Doesn't Dr. Kessler's initiative
need congressional approval?
Zeller: Congress' approval is not
required. Congress can act now, but it
does not require an act of Congress for
FDA authority. 10.
October 1995 '1T! 25
The industry has not presented any
argument to the contrary.
Zeller. The industry says cigarettes
are not addictive because they do not
intoxicate. Intoxication is just one pos-
sible criteria. And under no one's defi-
nition is it essential.
TR: Is it possible the FDA, if it reg-
ulated tobacco, would phase down
nicotine levels to what it deemed
nonaddictive levels?
Zeller. It's a theoretical proposition.
dOfVG2..E6S CA(tl ACT"
Now, F3ur tr 0065 Nar
2EQUi2.E AIV ACf" OF
COf\IG2.ESv Fd2. t-r At

4oU cAIV'T 56
Ma26 5Erz,oUs
r~Am T2201205imG
A 2U LE.
TR: Some tobacco compa-
nies have already
launched their own
efforts to reduce
teen smoking,
like Philip Morris'
Action Against
Access. Do the
industry's efforts go
far enough in your
opinion?
O'Hara: The President
has said voluntary efforts
will not work. If voluntary
efforts mean they're serious,
TR: What
actions has the
agency taken so far?
O'Hara: Documents
are on display in the Federal
Register, and they're available on
the Internet. We're accepting com-
ments until November 9th.
TR: Will FDA extend the com-
ment period?
O'Hara: The current comment period
is November 9. At times, the agency has
extended the comment period. But I
don't know of any decision made on this.
Big Star Warehouse
Wilson, North Carolina
The heart of U. S flue-cured tobacco country!
November 14-15-16,1996
~A.M.-5 P.M.
that's welcome. But what
we need are comprehen-
sive, enforceable measures.
TR: FDA argued it didn't have
jurisdiction over tobacco when anti-
tobacco group ASH petitioned it in
1980.
O'Hara: The court decision said
that if circumstances change, the
agency could revisit the issue.
TR: The President has stated
that if teen smoking is not reduce
by 50 percent from a 1993 statisti,
additional regulations may b
introduced. What, in your opir
ion, would additional regulatio
entail?
O'Hara: This is an area open L
comment, as to what would be appr(
priate.
TR: Some observers say FDA h<
no intention of regulating tobacco-
that actually it is attempting to forc
the issue in Congress.
O'Hara: We've proposed a rul~
Colleen. You can't be more seriou
than proposing a rule.
The President has said that '
Congress wants to act as compreher.
sively as his approach, he's willing t
take a look at that.
TR: Do you believe your curren
proposal will affect adults?
O'Hara: No. There is nothing in ou
proposal that affects access to adults tf
what will continue to be a legal prod
uct. Tn
MID-ATLi%iT1C FARM SHOW
You'll see the latest in tobacco-growing technology, along with equipment and supplies
for a wide range of other crops.
a
th
co
For more information contact: ~
~
~.
jim Swindeii, Mary Taylor or Marge Cazares
~
Specialized Agricultural Publications
3000 Highwoods Blvd., Suite 300,
Raleigh, NC 27604, USA
919/872-5040
9s Tn f1,r,tn}~g~r 1Qo1;

tobacco
_
" PASSPORT TO
. ,
R ;%:E'~~`P '0 =
R ;"T ::f :R
INDUSTRY RESPONDS:
uct AwiT
TR Staff Report
F ive U.S. tobacco companies
filed suit against the U.S. Food
and Drug Administration and
David Kessler, the Commis-
sioner of Food and Drugs, on 10
August-Brown & Williamson
Tobacco Corp., Liggett Group Inc.,
Lorillard Tobacco Co., Philip Morris
Inc. and R.J. Reynolds Tobacco Co.-
along with advertising agency Coyne-
Beahm Inc.
The complaint seeks judicial decla-
ration that the FDA has no authority
to regulate cigarettes as drugs, and
asks that the court enjoin FDA to
withdraw its rulemaking proceeding
to establish such authority.
The suit was filed in federal court
in the Middle District of North
Carolina.
In a 32-page complaint, the plain-
tiffs allege that FDA's action is con-
trary to Congress' intent to withhold
from FDA jurisdiction over cigarettes,
is irreconcilable with the existing
Federal Cigarette Labeling and
Advertising Act, and is beyond FDA's
authority in the Federal Food, Drug
and Cosmetic Act.
For 80 years Congress, the courts
and FDA have repeatedly affirmed
that FDA lacks authority to regulate
cigarettes, or nicotine in cigarettes, as
drugs.
The plaintiffs allege that FDA's ini-
tiative has had and will have a signifi-
cant negative impact on them. While
the FDA initiative has no immediate
legal effect, FDA's assertion of jurisdic-
tion is its final determination.
Accordingly, the plaintiffs are seeking
judicial review.
On Aug. 10, the plaintiffs gathered
to make a statement on their FDA
lawsuit. Speaking on behalf of the
group was Steve Parrish, senior vice
president, corporate affairs, for Philip
Morris Cos.
Following, his remarks:
"Today, [the plaintiffs] ... filed suit
in the U.S. District Court for the
Middle District of North Carolina in
order to stop the Food and Drug
Administration from proceeding on a
course of action that clearly is illegal.
"The suit follows FDA Commis-
sioner David Kessler's release of pro-
posed regulations governing ciga-
rettes. The regulations are based on
President Clinton's decision to allow
FDA to assert jurisdiction over ciga-
rettes under a federal law that gives
the FDA power to regulate medicines,
medical devices and pharmaceutical
products. The purported justification
for the FDA regulations is to prevent
minors from smoking.
"On this issue, all of us share a
common goal. Everyone agrees that
minors should not smoke and that
kids should not have access to ciga-
rettes. We support a number of steps,
both voluntary and by state legisla-
tion, that will make a real difference
on this issue.
"But regulating cigarettes as medi-
cines, medical devices or pharmaceu-
tical products defies logic, it defies
common sense, and-most impor-
tant-it defies the law.
"This lawsuit is not about youth
2R TR QnfnBer 1995

s7noking. This lawsuit is about
whether, in defiance of 80 vears of
clear precedent, David Kessler and the
FDA can regulate cigarettes.
"This lawsuit is about whether
David Kessler can unilaterally impose
a regulatory scheme that goes far, far
beyond his statutory authority.
"This lawsuit is about whether
David Kessler can ignore the authority
and repeated directions of Congress,
as well as numerous court decisions.
"David Kessler is trying to sneak
through the back door because
Congress has repeatedly slammed
shut the front door on the issue of
regulating cigarettes under the same
law the FDA applies to products sold
for therapeutic or medicinal purposes.
"David Kessler's action can only be
described as a Trojan Horse, set for-
ward under the guise of preventing
youth smoking. Make no mistake; the
real hidden agenda here is prohibi-
tion.
"We believe this lawsuit is our only
option in the face of an illegal action
that, if successful, even Commissioner
Kessler has admitted could lay the
groundwork for far more radical
action in the future-action that
could ultimately lead to severe restric-
tions or a ban on the sale of cigarettes
to adults.
"Despite what the Clinton
Administration says, Commissioner
Kessler simply does not have the
authority to regulate cigarettes as
medicines, medical devices or phar-
maceuticals. The law is clear. The
intent of Congress is clear. FDA is the
wrong government entity with the
wrong legal mandate.
"Time after time, for more than 80
years, FDA and its predecessor agen-
cies have informed Congress that cig-
arettes do not meet the criteria for reg-
ulation by FDA under existing federal
law, and Congress has agreed. In
amending the Federal Food, Drug and
Cosmetic Act nearly 70 times,
Congress has never given FDA juris-
diction over tobacco. In fact, on 20
occasions, Congress has failed to pass
legislation that would have granted
FDA jurisdiction over the tobacco
industry.
"Commissioner Kessler was right
last year when he told Congress that
he needed congressional direction
before regulating tobacco.
"Commissioner Kessler is wrong
now to reverse himself simply because
the direction he got was not the direc-
tion he wanted. And, despite what
President Clinton says, he does not
have the right to usurp the authority
of Congress when it comR, to this
issue.
"The law has not changed, the
key facts have not changed and
Commissioner Kessler's statutory
mandate from Congress has not
changed. The
stated
goal
cau2-4_5E OF Acrlam r~4rAr
iS CLE(A2LY iLLEGAL.
of pre
venting
youth smoking is a
laudable one-but it does
not justify a decision to
defy 80 years of clearly
stated FDA and congressional policy.
Simply put, Commissioner Kessler
and the Clinton Administration can-
not ignore the law and the constitu-
tional protections afforded Amer-
icans.
"The American people sent a very
clear message last year. As citizens we
want less government intrusion in our
daily lives. We want politicians to
start using some common sense.
Saying that cigarettes meet the strict
statutory definition of medicines,
medical devices or pharmaceutical
products just does not make sense.
"David Kessler and the anti-smok-
ing cabal would have the American
public believe that cigarettes are an
unregulated product. Nothing could
be further from the truth. Nine federal
government agencies, including the
Federal Trade Commission and the
Justice Department, oversee various
facets of the tobacco industry. But in
each of those cases, oversight has
been granted by Congress, and
Congress has never delegated the
authority to regulate cigarettes to the
FDA.
"Commissioner Kessler says his
regulatory goals are narrow and that
he does not want prohibition. But
in a letter dated Feb. 25, 19Q-k,
Commissioner Kessler «r<,re the tol-
lowing: 'A strict application of these
provisions could mean, ultimately,
removal from the market of tobacco
products contain-
ing nico-
tine at
PLAil`!?iF'F'r'- FILED
5uizr...iN a2vE2 ro 5roT"
t-r A F'2UM VQOCEEDiNG ON A
levels
that cause
or satisfv addic-
tion. Onlv those
tobacco products from
which the nicotine had
been removed or, possibly, tobacco
products approved by FDA for nico-
tine-replacement therapy would then
remain on the market.'
"Given the decision by the Clinton
Administration and the FDA that it
will regulate cigarettes, Commissioner
Kessler must now answer the follow-
ing questions:
Does FDA have the authoritv to
ban cigarettes sold to adults?
Does FDA believe-as Com-
missioner Kessler has stated that it
must in order to allow a drug or med-
ical product to remain on the mar-
ket-that cigarettes are "safe" and
"effective"?
Does FDA have the authority to
regulate the content of cigarettes?
"We do not believe most Ameri-
cans want an unelected bureaucrat to
wield the kind of power that could
effectively lead to a ban of cigarettes
for adults who choose to smoke.
"There are ways to deal with the
challenge of youth smoking without
creating the threat to personal liberty
and the affront to common sense that
I
I
I

the FDA regulation
would create. Some are in
place now, others are in the process of
being implemented.
"For example, under a recent feder-
al statute, the Department of Health
and Human Services is recommend-
ing a model law to the states aimed at
reducing minors' access to tobacco
products, tying block grants to states
to the enactment and enforcement
of such laws. The Federal Trade
Commission alreadv has broad
authority to oversee tobacco
advertising and promotional
practices, and Congress gave
the Departmer: of justice
the authority to enforce the
ban on broadcas` ea~rtisinb
of tobacco products.
"Multimillion dollar pro-
grams have been put in
place in many states to pre-
vent youth smoking, some
relying on state appropria-
tions, and mant ~ one
of several maior sources of feder-
al funding.
"Among other approaches
are increased voluntary actions
by the tobacco industry, including
cooperative efforts with others, and
granting further powers to the states
for education and enforcement.
"If the goal is to prevent the sale of
cigarettes to minors, we believe these
common-sense approaches will work.
Even President Clinton said as recent-
ly as Wednesday that Qovernment
alone cannot resolvt ti.rs issue. As
Philip Morris says regarding its own
program on youth access, the best
way to keep kids away from cigarettes
is to keep cigarettes away from kids.
"But we believe Commissioner
Kessler-with the blessing of the
Clinton Administration-has a much
different agenda. Commissioner
Kessler's initiative is an outright defi-
ance of Congress, which has retained
the right to decide how and by whom
cigarettes may be regulated.
"Congress has stated over and over
and over again that it never intended
to give FDA the authority that
Commissioner Kessler is now asserting
and that the Clinton Administration
has now endorsed. This is the reason
for our action today, and we will pur-
sue every appropriate remedy to see
that Commissioner Kessler's decision
is overturned.
"In doing so, we will vigorously
defend our right to continue to manu-
facture and sell cigarettes to adults,
and we will vigorously defend the
rights of adults in this country to pur-
chase cigarettes." 'R't
WITHOUT OUR
IDEAS, YOUR PRODUCTS
WOULD BE OUT OF SHAPE
When the garniture tape successfully combines
production speed with perfect rod quality, when
the suction tape transports tobacco with precision
and minimum waste, in short: when your machine
efficiency is high and your production costs are
low... you will find one of our ideas at work. Ideas
that have proven themselves: each and every ciga-
rette and filter making machine is originally
equipped with Esband®. There is no better re-
commendation. Count on the world's leading spe-
cialist for endless garniture and suction tapes,
drum tyres and high-performance
drive belts. Call us: Germany 7324- it*
150. Or send us a fax: Germany
7324-1515. Our ideas will optimize
your production process as well.
Schlatterer
Esband®
Puttinp Ilut in Motlon
C,
Fr
R
Pt
pr
